MARKET

MRK-WI

MERCK & CO
MRK-WI
NYSE
Delisted
P/E
P/S
P/B
MARKET CAP
26.97
3.961
7.05
189,904,377,300.00
FDA Approves Agilent PD-L1 Test for First-Line Ovarian Cancer Therapy
Reuters · 7h ago
Exelixis posts FY 2025 non-GAAP net income of USD 869.5 million
Reuters · 9h ago
Merck Executive VP Dean Y. Li Reports Disposal of Common Shares
Reuters · 9h ago
MERCK & CO INC: FDA APPROVES PEMBROLIZUMAB WITH PACLITAXEL FOR PLATINUM-RESISTANT EPITHELIAL OVARIAN, FALLOPIAN TUBE, PRIMARY PERITONEAL CARCINOMA
Reuters · 9h ago
Helus Pharma Names Michael Cola as Chief Executive Officer
Reuters · 17h ago
CALLA LILY CLINICAL CARE AND MERCK ANNOUNCE STRATEGIC COLLABORATION TO ADVANCE INTRAVAGINAL DRUG DELIVERY PLATFORM
Reuters · 20h ago
Merck Chief Marketing Officer Chirfi Guindo Reports Disposal of Common Shares
Reuters · 1d ago
Merck EVP and General Counsel Jennifer Zachary Reports Disposal of Common Shares
Reuters · 1d ago
More

Webull offers MERCK & CO stock information, including NYSE: MRK-WI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK-WI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRK-WI stock methods without spending real money on the virtual paper trading platform.